Arix Bioscience plc Director/PDMR Shareholding

 
TIDMARIX 
 
ARIX BIOSCIENCE PLC 
 
Director/PDMR Shareholding 
 
LONDON, 13 March 2020: Arix Bioscience plc (LSE:ARIX) ("Arix"), a global 
venture capital company focused on investing in and building breakthrough 
biotech companies, today announces a conditional share award to Jonathan 
Peacock, Chairman, relating to his service in 2019 as an Executive Director. 
The award is subject to performance conditions over a three year assessment 
period, consistent with the awards made to other Executive Directors in 2019, 
as detailed on page 70 of the Annual Report and Accounts. 
 
PDMR DEALING NOTIFICATION 
 
Notification and public disclosure of transactions by persons discharging 
managerial responsibilities and persons closely associated with them 
 
 1  Details of the person discharging managerial responsibilities / person closely 
    associated 
 
a)  Name              Jonathan Peacock 
 
 2  Reason for the notification 
 
a)  Position / status Chairman 
 
b)  Initial           Initial Notification 
    notification / 
    Amendment 
 
 3  Details of issuer 
 
a)  Name              Arix Bioscience plc 
 
b)  LEI               213800OVT3AHQCXNIX43 
 
 4  Details of the transaction(s): section to be repeated for (i) each type of 
    instrument; (ii) each type of transaction; (iii) each date; and (iv) each place 
    where transactions have been conducted 
 
a)  Description of    Ordinary Shares of Arix Bioscience plc 
    the financial 
    instrument, type 
    of instrument 
 
    Identification    GB00BD045071 
    code 
 
b)  Nature of the     Conditional share award 
    transaction 
 
c)  Price(s) and      Price(s)                Volume(s) 
    volume(s) 
                      Nil                     231,348 
 
d)  Aggregated        Aggregated price        Aggregated volume 
    information 
                      N/A (single             N/A (single transaction) 
                      transaction) 
 
e)  Date of the       12 March 2020 
    transaction 
 
f)  Place of the      Outside a trading venue 
    transaction 
 
For further information: 
 
Robert Lyne    Chief Operating Officer and General Counsel           +44 (0)207 
290 1050 
 
 - Ends - 
 
 
 
END

(END) Dow Jones Newswires

March 16, 2020 03:00 ET (07:00 GMT)

Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Apr 2024 to May 2024